Medscape
Update on the Management of
Atopic Dermatitis
What Clinicians Need to Know
Michael J. Cork, BSc, MB, PhD, FRCP
Consultant Dermatologist, Sheffield Children's Hospital and Teaching Hospitals
Head of Sheffield Dermatology Research (SDR)
Department of Infection, Immunity and Cardiovascular Disease
University of Sheffield
Medical School
Sheffield, United KingdomBackground
* AD is a chronic, relapsing inflammatory skin diseasel*l
* AD places a significant burden on patients by
negatively affecting:!!
— Quality of life
— Work
— Family
* Burden is felt by patients with mild to moderate and
moderate to severe AD!)
a. Zuberbier T, et al. J Allergy Clin Immunol. 2006;118:226-232.
b. Hebert AA, et al. Curr Med Res Opin. 2018;34:2177-2185.Burden of AD: Severe Disease
“It was too painful to move or be exposed to the air. My ankles, feet and legs
swelled up and | could not stand or use my hands”
Images courtesy of Michael J. Cork, BSc, MB, PhD, FRCP.